Cognition Therapeutics, Inc. (CGTX)
NASDAQ: CGTX · Real-Time Price · USD
1.020
-0.040 (-3.77%)
At close: Aug 28, 2026, 4:00 PM EDT
1.040
+0.020 (1.99%)
After-hours: Aug 28, 2026, 7:59 PM EDT
Cognition Therapeutics Market Cap
Cognition Therapeutics has a market cap or net worth of $97 million as of August 28, 2026. Its market cap has decreased by -56.86% in one year.
Market Cap
97.00M
Enterprise Value
63.57M
1-Year Change
-56.86%
Ranking
Category
Stock Price
$1.02
ChartMarket Cap Chart
Since the IPO on October 8, 2021, Cognition Therapeutics's market cap has decreased from $256.46M to $97.00M, a decrease of -62.18%. That is a compound annual growth rate of -18.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 97.00M | -18.61% |
| Dec 31, 2025 | 119.17M | 308.99% |
| Dec 31, 2024 | 29.14M | -50.97% |
| Dec 29, 2023 | 59.43M | -2.39% |
| Dec 30, 2022 | 60.88M | -56.29% |
| Dec 31, 2021 | 139.27M | -45.69% |
| Oct 8, 2021 | 256.46M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Oncolytics Biotech | 108.38M |
| Yarrow Bioscience | 106.40M |
| Polaryx Therapeutics | 105.18M |
| PolyPid | 104.00M |
| Kalaris Therapeutics | 97.60M |
| Adicet Bio | 96.99M |
| Pelthos Therapeutics | 95.71M |
| Fortress Biotech | 93.38M |